Literature DB >> 22073930

Peripheral blood immunologic phenotype of population-based breast cancer cases and matched controls.

James J Goedert, Ruth Pfeiffer, Mingzhu Zhu, Xiaohong R Yang, Montserrat Garcia-Closas, Jolanta Lissowska, William C Kopp.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22073930      PMCID： PMC3288213          DOI： 10.1111/j.1365-2362.2011.02610.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN： 0014-2972            Impact factor:   4.686


× No keyword cloud information.
  10 in total

1.  Whole blood cryopreservation in epidemiological studies.

Authors:  Richard B Hayes; Craig O Smith; Wen-Yi Huang; Yvonne Read; William C Kopp
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-11       Impact factor: 4.254

2.  Analysis of naïve and memory CD4 and CD8 T cell populations in breast cancer patients receiving a HER2/neu peptide (E75) and GM-CSF vaccine.

Authors:  Matthew T Hueman; Alexander Stojadinovic; Catherine E Storrer; Zia A Dehqanzada; Jennifer M Gurney; Craig D Shriver; Sathibalan Ponniah; George E Peoples
Journal:  Cancer Immunol Immunother       Date:  2006-06-17       Impact factor: 6.968

3.  Treatment of breast cancer cells with proteasome inhibitor lactacystin increases the level of sensitivity to cell death induced by human immunodeficiency virus type 1.

Authors:  Masafumi Endo; Shouichirou Gejima; Asako Endo; Nobutoki Takamune; Shozo Shoji; Shogo Misumi
Journal:  Biol Pharm Bull       Date:  2010       Impact factor: 2.233

Review 4.  CD4 regulatory T cells in human cancer pathogenesis.

Authors:  Keith L Knutson; Mary L Disis; Lupe G Salazar
Journal:  Cancer Immunol Immunother       Date:  2006-07-04       Impact factor: 6.968

5.  Homeostasis of peripheral FoxP3(+) CD4 (+) regulatory T cells in patients with early and late stage breast cancer.

Authors:  Andrew J Rech; Rosemarie Mick; David E Kaplan; Kyong-Mi Chang; Susan M Domchek; Robert H Vonderheide
Journal:  Cancer Immunol Immunother       Date:  2009-10-24       Impact factor: 6.968

6.  HIV tropism and decreased risk of breast cancer.

Authors:  Nancy A Hessol; Laura A Napolitano; Dawn Smith; Yolanda Lie; Alexandra Levine; Mary Young; Mardge Cohen; Howard Minkoff; Kathryn Anastos; Gypsyamber D'Souza; Ruth M Greenblatt; James J Goedert
Journal:  PLoS One       Date:  2010-12-16       Impact factor: 3.240

7.  Risk of breast, ovary, and uterine corpus cancers among 85,268 women with AIDS.

Authors:  J J Goedert; C Schairer; T S McNeel; N A Hessol; C S Rabkin; E A Engels
Journal:  Br J Cancer       Date:  2006-07-25       Impact factor: 7.640

8.  Established breast cancer risk factors by clinically important tumour characteristics.

Authors:  M García-Closas; L A Brinton; J Lissowska; N Chatterjee; B Peplonska; W F Anderson; N Szeszenia-Dabrowska; A Bardin-Mikolajczak; W Zatonski; A Blair; Z Kalaylioglu; G Rymkiewicz; D Mazepa-Sikora; R Kordek; S Lukaszek; M E Sherman
Journal:  Br J Cancer       Date:  2006-06-06       Impact factor: 7.640

9.  Breast cancer risk in elderly women with systemic autoimmune rheumatic diseases: a population-based case-control study.

Authors:  S M Gadalla; S Amr; P Langenberg; M Baumgarten; W F Davidson; C Schairer; E A Engels; R M Pfeiffer; J J Goedert
Journal:  Br J Cancer       Date:  2009-02-03       Impact factor: 7.640

10.  A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis.

Authors:  Allison L Smitten; Teresa A Simon; Marc C Hochberg; Samy Suissa
Journal:  Arthritis Res Ther       Date:  2008-04-23       Impact factor: 5.156
  10 in total
  1 in total

1.  Combined peripheral natural killer cell and circulating tumor cell enumeration enhance prognostic efficiency in patients with metastatic triple-negative breast cancer.

Authors:  Xiaoran Liu; Ran Ran; Bin Shao; Hope S Rugo; Yanlian Yang; Zhiyuan Hu; Zewen Wei; Fengling Wan; Weiyao Kong; Guohong Song; Hanfang Jiang; Xu Liang; Ruyan Zhang; Ying Yan; Guobing Xu; Huiping Li
Journal:  Chin J Cancer Res       Date:  2018-06       Impact factor: 5.087
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.